With the acquisition of a site in Germany, U.S.-based integrated site organization (ISO) Velocity Clinical Research has made its first strides toward expanding into Europe.

The ISO recently announced that it acquired its first site in Europe, Clinical Research Hamburg, for an undisclosed amount. The sale marks its first purchase in a line of deals planned across the UK and Germany.

According to Velocity, the move makes it the first U.S.-based research site business to extend its reach into Europe. The company, whose site count now stands at 32 integrated sites, “has a pipeline of deals to significantly expand its European network of sites” by the end of the year, it said.